Meridian Bioscience Achieves IVDR Certification for Alethia® Molecular Assay Portfolio February 23, 2026 Read More
Meridian Life Science Expands Ambient-Stable NGS Portfolio with the Launch of a Lyophilized Enzymatic DNA Fragmentation Kit. February 18, 2026 Read More
Meridian Bioscience Appoints New CEO and Executive Team to Accelerate Global Growth October 16, 2025 Read More
Rethinking Campylobacter: Fast, Accurate Diagnostics for Better GI Outcomes September 30, 2025 Read More
Shiga Toxin-Producing E. coli: The Urgent Need for Accurate, Antibiotic-Free Management September 29, 2025 Read More